Log In
Print this Print this

ralinepag (APD811)

  Manage Alerts
Collapse Summary General Information
Company Arena Pharmaceuticals Inc.
DescriptionProstacyclin (IP) receptor (PGI2) agonist
Molecular Target Prostacyclin (IP) receptor (PGI2) (PTGIR)
Mechanism of ActionProstacyclin (IP) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation U.S. - Orphan Drug (Treat pulmonary arterial hypertension (PAH))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today